Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus the standard of care treatments Acyclovir and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Parents have been struggling through a rough virus season, and keeping children’s toys, clothes, and accessories clean and ...

According to new findings from University of Michigan scientists, eating too much fat could seriously hobble your immune ...

Pooling data from seven studies that tracked nearly 250,000 volunteers for up to 17 years, researchers found that ...

There isn’t a quick, one-off cure for a cold. You can do a lot to support healing, though. Here, find out how to self-treat a ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Wednesday was the final day of a three-week medical malpractice lawsuit trial tied to a surgery that former Timbers goalie Jake Gleeson says cost his career.

The FDA approval is based on late-stage data, which shows that GSK's Blujepa is at least as effective as a leading standard treatment for uncomplicated UTIs.

Health experts are raising awareness about invasive meningococcal disease (IMD), a rare but serious bacterial infection that can progress rapidly, sometimes becoming life-threatening within just 24 ...

Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...

Early diagnosis and treatment of active Tuberculosis is utmost priority, but identifying the latent TB, especially among the ...